Wider use of tranexamic acid to reduce surgical bleeding could benefit patients and health systems

BMJ. 2024 Jun 12:385:e079444. doi: 10.1136/bmj-2024-079444.

Abstract

Ian Roberts and colleagues call for greater use of this inexpensive generic drug that can improve surgical outcomes, avoid unnecessary blood transfusion, and conserve blood stocks

Publication types

  • News

MeSH terms

  • Antifibrinolytic Agents* / therapeutic use
  • Blood Loss, Surgical* / prevention & control
  • Humans
  • Tranexamic Acid* / therapeutic use

Substances

  • Tranexamic Acid
  • Antifibrinolytic Agents